5432452026-10-012026-10-015432452026-10-015432452026-10-01ChangeInManagementDomain15432452026-10-012026-10-01ChangeInManagementDomain15432452026-10-01ChangeInManagementDomain25432452026-10-012026-10-01ChangeInManagementDomain25432452026-10-01ResignationOfDirectorOrKeyManagerialPersonnelOrSeniorManagementPersonnelOrComplianceOfficerDomain15432452026-10-012026-10-01ResignationOfDirectorOrKeyManagerialPersonnelOrSeniorManagementPersonnelOrComplianceOfficerDomain1xbrli:pureGLANDGLAND PHARMA LIMITED543245NOTLISTEDINE068V01023trueListed Entity (self)true2026-10-0115:00:0015:30:0022026-10-01CessationResignationDirectorNon - Executive Non -Independent DirectorNot ApplicableNot ApplicableMr.Wenjie Zhang2026-10-01trueAppointmentDirectorNon - Executive Non -Independent DirectorNot ApplicableNot ApplicableMr.Xingli Wang2026-10-015Mr. Xingli Wang, aged 63, is currently the President of Fosun Pharma, and holds positions including the Chief Executive Officer of the Global R&D Center and Chief Executive Officer of innovative medicine division, Fosun Pharma and Non-Executive Director of Shanghai Henlius (stock code: 02696), a subsidiary listed on the Hong Kong Stock Exchange. Mr. Wang joined the Fosun Group in January, 2023 and served as the Executive President of Fosun Pharma from January, 2023 to June, 2025. Prior to joining the Fosun Group, Mr. Wang served as a Senior lecturer in Cardiovascular Medicine at The University of New South Wales (“UNSW”), Australia, and as a cardiologist and professor with tenure at Baylor College of Medicine, USA, Medical Director of Schering-Plough Corporation, a company formerly listed on the New York Stock Exchange (stock code: SGP) (merged into Merck & Co., Inc. in 2009). He also worked in Novartis AG (stock code: NVS), a company listed on the New York Stock Exchange, where he successively served as Project Supervisor, Global Project Clinical Head, Head of Novartis Global Drug R&D (China) and General Manager of Biomedical Research Institute (China). Mr. Wang obtained a Bachelor’s degree in Medicine from Shandong Medical College (merged into Shandong University in 2000) and a Doctorate degree in Cardiovascular Science from the UNSW. Mr. Wang also holds a license to practice Medicine in Australia.Not ApplicabletruefalseMr.Wenjie ZhangNon - Executive Non -Independent Director2026-10-012026-10-01trueDue to Preoccupations